Omkar Speciality Chemicals Ltd.

NSE: OMKARCHEM BSE: 533317 SECTOR: Chemicals  3910   16   0

38.95
-2.05 (-5.00%)
NSE: Today, 03:41 PM

Price Summary

Today's High

₹ 40.5

Today's Low

₹ 38.95

52 Week High

₹ 42.15

52 Week Low

₹ 5

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

80.15 Cr.

Enterprise Value

307.98 Cr.

No. of Shares

2.06 Cr.

P/E

0

P/B

0

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  -79.78

CASH

0.26 Cr.

DEBT

228.09 Cr.

Promoter Holding

17.62 %

EPS (TTM)

₹  -1.28

Sales Growth

-20.66%

ROE

0 %

ROCE

12.4%

Profit Growth

113.76 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-20.66%
3 Year-38.24%
5 Year-31.54%

Profit Growth

1 Year113.76%
3 Year26.4%
5 Year-38.13%

ROE%

1 Year0%
3 Year0%
5 Year-24.49%

ROCE %

1 Year12.4%
3 Year2.43%
5 Year-21.05%

Debt/Equity

-1.4406

Price to Cash Flow

-4.88

Interest Cover Ratio

1.5657367655248

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2021 17.62 63.89
Jun 2021 27.62 76.94
Mar 2021 27.62 76.94
Dec 2020 27.62 76.94
Sep 2020 27.62 76.94
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -34.6603034610509 days.

 Limitations

  • The company has shown a poor revenue growth of -38.2434176227412% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Promoter pledging has increased from 17.62% to 63.89% in 1 quarter.
  • Company has a poor ROCE of 2.43266604326675% over the past 3 years
  • Company has contingent liabilities of 45.2443 Cr.
  • Company has negative cash flow from operations of -16.412.
  • The company has a low EBITDA margin of 1.2351162383532% over the past 5 years.
  • The company has negative book value.
  • The company is trading at a high EV/EBITDA of 167.6138.
  • Promoter stake has been decreased from 27.62% to 17.62%.
  • Promoter pledging is high as 63.89%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021
Net Sales 16.86 12.16 10.97 7.36 4.23
Total Expenditure 13.81 9.2 10.77 7.76 6.56
Operating Profit 3.06 2.96 0.19 -0.39 -2.33
Other Income 0.08 0.55 0.11 0.02 0.72
Interest 1.59 1.52 1.21 1.43 1.49
Depreciation 0.98 0.98 0.57 0.47 0.47
Exceptional Items 0 0 4.05 0 0
Profit Before Tax 0.56 1.01 2.57 -2.28 -3.56
Tax 0.4 0.4 -0.01 0 0
Profit After Tax 0.16 0.61 2.59 -2.28 -3.56
Adjusted EPS (Rs) 0.08 0.3 1.26 -1.11 -1.73

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 316.74 191.59 42.65 56.88 45.12
Total Expenditure 259.43 234.95 44.53 57.12 37.75
Operating Profit 57.31 -43.36 -1.88 -0.24 7.37
Other Income 2.25 3.69 3.04 0.45 0.86
Interest 21.83 26.13 14.62 4.93 5.57
Depreciation 10.9 8.16 7.99 6.59 3.56
Exceptional Items -163.62 -52.59 9.93 0 4.04
Profit Before Tax -136.79 -126.55 -11.52 -11.31 3.15
Tax -27.43 -22.58 5.35 3.32 1.14
Net Profit -109.36 -103.97 -16.87 -14.64 2.01
Adjusted EPS (Rs.) -53.14 -50.52 -8.2 -7.11 0.98

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 20.58 20.58 20.58 20.58 20.58
Total Reserves -23.39 -145.66 -168.66 -183.07 -178.91
Borrowings 57.9 76.4 74.32 73.83 66.63
Other N/C liabilities -13.37 -15.07 -9.68 -6.45 -5.19
Current liabilities 251.27 183.94 180.05 185.13 177.22
Total Liabilities 292.99 120.18 96.61 90.02 80.33
Assets
Net Block 82.5 76.14 68.43 53.14 27.91
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.57 1.09 0.35 0.38 0.71
Loans & Advances 18.04 7.59 6.33 6.28 5.35
Other N/C Assets 0.3 0.24 0.31 0.12 0.04
Current Assets 191.58 35.13 21.2 30.1 46.32
Total Assets 292.99 120.18 96.61 90.02 80.33
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations -136.79 -126.55 -11.52 -11.31 3.15
Adjustment 187.07 90.51 11.56 14.4 4.61
Changes in Assets & Liabilities 50.27 62.55 1.33 0.93 -24.17
Tax Paid 6.75 -0.56 0 0 0
Operating Cash Flow 107.3 25.96 1.38 4.02 -16.41
Investing Cash Flow -119.9 -64.33 10.9 1.51 17.35
Financing Cash Flow 15.75 35.24 -13.55 -5.3 -1.08
Net Cash Flow 3.16 -3.13 -1.28 0.23 -0.14

Corporate Actions

Investors Details

PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Promoters 27.62 27.62 27.62 27.62 17.62
pravin shivdas her... 23.26 18.84 17.18 14.10 13.27
omkar pravin herle... - - 6.10 9.19 -
rishikesh pravin h... 2.51 2.51 2.51 2.51 2.51
svaks biotech indi... 1.85 - - - -
svaks biotech indi... - 1.85 1.85 1.85 1.85
PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Investors 72.38 72.38 72.38 72.38 82.38
shashank ashok saw... - 1.27 - - -
ravi pareek - - - 1.11 -
mohammed arshad - - - 1.01 -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Omkar SpecialityChem Stock Price Analysis and Quick Research Report. Is Omkar SpecialityChem an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Omkar SpecialityChem has a PE ratio of -30.313643085065 which is low and comparatively undervalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Omkar SpecialityChem has ROA of 2.36414890756737 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Omkar SpecialityChem has a Current ratio of 0.261378877999152 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Omkar SpecialityChem has a ROE of 0 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Omkar SpecialityChem has a D/E ratio of -1.4406 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Omkar SpecialityChem has an Inventory turnover ratio of 17.513350927579 which shows that the management is efficient in relation to its Inventory and working capital management.

  • Sales growth: - Omkar SpecialityChem has reported revenue growth of -20.6627248480501 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Omkar SpecialityChem for the current financial year is 16.3339974160608 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Omkar SpecialityChem is Rs 0 and the yield is 0 %.

Brief about Omkar SpecialityChem

X